Limelight Bio emerges with $75m to develop next generation gene therapies to overcome...

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Dec 6, 2019 at 10:32 AM.

  1. #1 cafead, Dec 6, 2019 at 10:32 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,028
    Likes Received:
    3
    via Founded in 2017, Limelight Bio has developed proprietary technologies, advanced targets and leading drug candidates designed to overcome key limitations of current gene therapy and gene editing approaches.

    article source
     
    Quote

Reply to Thread